Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Stellate Ganglion Block for Dysphagia in Cerebral Palsy
NCT06304090Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lidocaine in dysphagia (2 arms). Primary endpoint: Penetration-Aspiration Scale at Day 10. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT06304090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06304090.